EHS
EHS

Daily oral insulin improves metabolic markers in children at high risk for type 1 diabetes



Daily oral insulin therapy may improve glucose and C-peptide measurements for a subset of children at high risk for type 1 diabetes, according to new TrialNet data presented at the American Diabetes Association Scientific Sessions.
“The main message is that, in the subset of participants with the highest risk for type 1 diabetes, one of the two doses of oral insulin that our study tested prevented deterioration of metabolic indices,” Maria Jose Redondo, MD, PhD, MPH, associate professor of pediatrics, diabetes and endocrinology at Texas Children’s Hospital and Baylor College of

Source link

EHS
Back to top button